Recommendations for Prescribing Specialist Infant Formula

Specialist infant formulas (SIFs) are therapeutic milks designed for infants with specific medical or nutritional needs that cannot be met by standard breastmilk or cowmilkbased formulas. Correct prescribing of these products is essential for the health and development of vulnerable infants, and it requires a systematic, evidencebased approach.

1. When to Consider Specialist Infant Formula

Medical Indications

• Preterm or lowbirthweight infants (<37weeks gestation or <2500g) who need extra protein, calories, and micronutrients.
• Failure to thrive when growth velocity remains below the 3rd percentile despite adequate intake of standard formula.
• Allergic or intolerant conditions such as cowmilk protein allergy (CMPA), lactose intolerance, or metabolic disorders (e.g., phenylketonuria).
• Gastrointestinal disorders like short bowel syndrome, malabsorption, or severe gastrooesophageal reflux.
• Neurological or muscular diseases that increase energy requirements (e.g., cerebral palsy, spinal muscular atrophy).

NonMedical Situations

• Parents who are unable or unwilling to breastfeed and need a formula with specific nutritional enhancements.
• Infants undergoing surgery or receiving longterm parenteral nutrition who require transitional enteral feeding.

2. Assessment Before Prescription

2.1 Clinical Evaluation

• Document gestational age, birth weight, current weight, length, head circumference, and growth trends.
• Perform a thorough medical history, focusing on allergy symptoms, gastrointestinal signs, and any underlying metabolic disorders.
• Review the infants current feeding regimen, including volume, frequency, and any supplemental feeds.

2.2 Laboratory Investigations

• Basic metabolic panel (electrolytes, glucose, urea, creatinine) for infants with suspected renal or metabolic disease.
• Serum albumin, prealbumin, and transferrin when evaluating proteinenergy malnutrition.
• Specific tests as indicated: stool elastase for pancreatic insufficiency, serum IgE for suspected allergy, urine organic acids for inborn errors of metabolism.

2.3 Nutritional Assessment Tools

• Use WHO growth standards or INTERGROWTH21st curves for preterm infants.
• Apply the Standardized Pediatric Nutritional Assessment (SPNA) scoring system to gauge severity of malnutrition.

3. Choosing the Appropriate Specialist Formula

3.1 Categorization of SIFs

• Preterm / LowBirthWeight Formulas higher protein (3.54.5g/100ml), calories (8085kcal/100ml), and fortified with minerals such as calcium, phosphorus, and zinc.
• Hypoallergenic Formulas extensively hydrolyzed (eHF) or aminoacidbased (AAF) for CMPA.
• LactoseFree Formulas for primary lactose intolerance or secondary lactase deficiency.
• Therapeutic Formulas for Metabolic Disorders phenylalaninerestricted, lowprotein, or specific fattyacid enriched formulas.
• HighEnergy Formulas for infants with increased caloric needs (e.g., neuromuscular disease).
• Modular Formulas allow addition of protein, carbohydrate, or fat modules for individualized nutrition.

3.2 Matching Formula to Indication

Follow a stepwise algorithm:

1. Identify the primary clinical problem (e.g., prematurity, allergy, metabolic condition).
2. Check the infants current nutrient intake against recommended daily allowances (RDA) for their age/weight.
3. Select the formula that most closely meets the deficit while addressing the specific pathology.
4. Consider patientspecific factors such as tolerability, feeding method (bottle vs. tube), and family preferences.

4. Initiation and Titration

4.1 Starting Dose

• Begin with 2030ml/kg/day for preterm infants; increase by 2030ml/kg/day as tolerated.
• For CMPA, start with a low volume (e.g., 5ml) and observe for any allergic reaction before advancing.
• In metabolic disorders, adhere strictly to prescribed protein or phenylalanine limits from day one.

4.2 Monitoring Parameters

• Weight gain: aim for 15g/day in preterms, 20g/day thereafter.
• Serum electrolytes and BUN/creatinine every 12weeks during the first month.
• Growth charts updated weekly for the first 4weeks, then biweekly.
• Specific markers: serum IgE for allergy, phenylalanine levels for PKU, stool pH for lactose intolerance.

4.3 Adjustments

If growth falters or labs become abnormal:

• Increase caloric density (e.g., from 67kcal/100ml to 80kcal/100ml) before increasing volume.
• Switch to an aminoacidbased formula if signs of persistent allergy develop despite eHF.
• Add modular protein or fat modules under a dietitians guidance for specific deficits.

5. Multidisciplinary Collaboration

Effective prescribing hinges on teamwork:

• Pediatricians/Neonatologists diagnose, order labs, and write the prescription.
• Clinical Dietitians calculate precise nutrient needs, select formula, and plan upgrades.
• Nurses monitor daily intake, manage feeding devices, and educate parents.
• Pharmacists verify formulation, ensure correct labeling, and manage supply logistics.
• Allergy Specialists confirm CMPA and guide reintroduction protocols.

6. Education and Support for Families

Key Topics to Cover

• Rationale for using specialist formula and expected benefits.
• Correct preparation (water temperature, sterilization, mixing ratios).
• Signs of intolerance or adverse reactions (vomiting, rash, poor weight gain).
• How to store formula safely and the shelflife of opened containers.
• When and how to contact the healthcare team.

Resources

• Printable feeding log sheets.
• Links to national infant nutrition guidelines (e.g., ESPGHAN, AAP).
• Contact information for 24hour helpline or oncall nurse.

7. FollowUp and LongTerm Planning

Specialist formulas are usually transitional:

• Preterm infants may shift to a term formula or fortified breastmilk by 3640weeks postmenstrual age.
• Allergyrelated formulas are typically used for 36months, followed by an oral foodchallenge to assess tolerance.
• Metabolic formulas often become a lifelong requirement; regular metabolic clinic reviews are essential.

Schedule routine visits:

• Weekly for the first month after initiation, then every 24weeks until growth stabilizes.
• Every 3months thereafter, or sooner if problems arise.

8. Safety and Regulatory Considerations

• Prescribe only formulas that are authorized by the national regulatory agency (e.g., FDA, EMA).
• Document the indication, dosage, and expected duration in the medical record.
• Report any suspected adverse events to the pharmacovigilance system.

9. Summary Checklist for Clinicians

1. Confirm the specific medical indication for SIF.
2. Complete growth and laboratory assessment.
3. Choose the formula category that matches the infants needs.
4. Start at the recommended initial volume and titrate gradually.
5. Monitor weight, growth, and relevant labs closely.
6. Engage dietitian, nursing, pharmacy, and allergy specialists as needed.
7. Educate caregivers on preparation, administration, and warning signs.
8. Plan regular followup and a clear transition strategy.

By adhering to these evidencebased recommendations, healthcare professionals can ensure that infants who require specialist nutrition receive the optimal formula, dosing, and support needed for healthy growth and development.